Nurbaid, Satah T.

HRN: 29-14-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/16/2026
06/22/2026
IV
600 Mg
Q8h
Fungating Breast Mass Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: